Waterstone Capital Management’s Oxford Immunotec Global PLC Ordinary Shares OXFD Stock Holding History

Waterstone Capital Management’s Portfolio OXFD Stock Details OXFD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-62,461	Closed	-$851K	–	27
2014 Q4	$851K	Sell	62,461 -23,819	-28%	-$326K	0.41%	19
2014 Q3	$1.32M	Sell	86,280 -11,159	-11%	-$171K	0.57%	17
2014 Q2	$1.64M	Buy	97,439 +72,439	+290%	+$1.3M	0.93%	12
2014 Q1	$502K	Buy	+25,000	New	+$541K	0.13%	23

Other funds holding OXFD

Clarus Ventures Cambridge, Massachusetts $425M AUM 26.13% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

NLVP

New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

TAM

Tiverton Asset Management Wilimington, Delaware $2.88B AUM 5.6% 1-Year Est. Return

LPU

Lansdowne Partners (UK) London, United Kingdom $1.87B AUM 61.55% 1-Year Est. Return

CAM

Cortina Asset Management Milwaukee, Wisconsin $1.62B AUM 15.44% 1-Year Est. Return

OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

Waterstone Capital Management's OXFD Position: Q1 2015 in Review

Waterstone Capital Management sold out of Oxford Immunotec Global PLC Ordinary Shares (OXFD) in Q1 2015, closing a stake of 62,461 shares — an estimated $851K sold.

Waterstone Capital Management first reported a position in OXFD in Q1 2014 and held it in 4 quarters. The position peaked at $1.64M in Q2 2014. 58 funds tracked by Wall St. Rank hold OXFD as of Q1 2015.

Waterstone Capital Management reported no remaining Oxford Immunotec Global PLC Ordinary Shares position as of Q1 2015 after selling out during the quarter.
Waterstone Capital Management sold 62,461 Oxford Immunotec Global PLC Ordinary Shares shares in Q1 2015, an estimated $851K.
Waterstone Capital Management first reported a position in Oxford Immunotec Global PLC Ordinary Shares in Q1 2014 and held it in 4 quarters.
Waterstone Capital Management's Oxford Immunotec Global PLC Ordinary Shares position peaked at $1.64M in Q2 2014.
58 funds tracked by Wall St. Rank held Oxford Immunotec Global PLC Ordinary Shares as of Q1 2015.

Based on Waterstone Capital Management's 13F filing for Q1 2015, filed 15 May 2015.